Procter & Gamble Health · NSE: PGHL · BSE: 500126
Q1 FY26 results · Apr–Jun 2025
Procter & Gamble Health reported revenue from operations of ₹338.74 crore (up 19.3% from Q1 FY25) and net profit of ₹66.18 crore (up 294.4% from Q1 FY25) for Q1 FY26 (Apr–Jun 2025), on a standalone basis.
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 338.74 | 283.88 | +19.3% | — | — |
| Other income | 4.03 | 2.13 | +89.2% | — | — |
| Total income | 342.77 | 286.01 | +19.8% | — | — |
| Profit before tax | 88.81 | 22.83 | +289.0% | — | — |
| Net profit for the period | 66.18 | 16.78 | +294.4% | — | — |
| EPS, basic (₹) | 39.87 | 10.11 | +294.4% | — | — |
| Net margin (%) | 19.5 | 5.9 | — |
Standalone
- Filed with BSE
- 01 Aug 2025, 15:37 IST
- Board meeting
- 01 Aug 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE